U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664410) titled 'Theranostic PET for Target Validation and Tumor Detection' on June 17.
Brief Summary: Patients are referred for theranostic PET using different tracers as part of clinical routine for tumor staging, re-staging, and therapy planning to our department.
The aim of this study is to collect data on the expression of target molecules/receptors, proportion of PET positive tumor regions, positive predictive value, detection rate, reproducibility, and impact on clinical management of theranostic PET/CT or PET/MRI using novel theranostic PET tracers or other established PET tracers that are performed in theranostic concepts on patients recei...